Shanghai Bio-heart Biological Technology Past Earnings Performance
Past criteria checks 0/6
Shanghai Bio-heart Biological Technology has been growing earnings at an average annual rate of 10.5%, while the Medical Equipment industry saw earnings growing at 10.9% annually.
Key information
10.5%
Earnings growth rate
44.1%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | n/a |
| Return on equity | -24.4% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Feb 22
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Nov 03We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth
May 12We're Not Worried About Shanghai Bio-heart Biological Technology's (HKG:2185) Cash Burn
Sep 19Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans
Jun 03Revenue & Expenses BreakdownBeta
How Shanghai Bio-heart Biological Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -176 | 53 | 112 |
| 30 Sep 23 | 0 | -182 | 62 | 133 |
| 30 Jun 23 | 0 | -189 | 71 | 155 |
| 31 Mar 23 | 0 | -197 | 83 | 156 |
| 31 Dec 22 | 0 | -204 | 94 | 158 |
| 30 Sep 22 | 0 | -234 | 120 | 161 |
| 30 Jun 22 | 0 | -263 | 145 | 165 |
| 31 Mar 22 | 0 | -312 | 170 | 190 |
| 31 Dec 21 | 0 | -361 | 195 | 214 |
| 30 Sep 21 | 0 | -437 | 190 | 284 |
| 30 Jun 21 | 0 | -512 | 184 | 354 |
| 31 Mar 21 | 0 | -419 | 133 | 300 |
| 31 Dec 20 | 0 | -326 | 82 | 246 |
Quality Earnings: 2185 is currently unprofitable.
Growing Profit Margin: 2185 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2185 is unprofitable, but has reduced losses over the past 5 years at a rate of 10.5% per year.
Accelerating Growth: Unable to compare 2185's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2185 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.2%).
Return on Equity
High ROE: 2185 has a negative Return on Equity (-24.4%), as it is currently unprofitable.